Form 4: Aura Biosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Janet Jill Hopkins, Chief Medical Officer of Aura Biosciences, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Grant/award: acquired 58,850 Common Stock on September 1, 2026; holds 380,190 after (Direct).
- Grant/award: acquired 116,150 Stock Option (Right to Buy) on September 1, 2026; holds 116,150 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Janet Jill Hopkins — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 58,850 | — | — | 380,190 |
| 2026-09-01 | Grant/award | Stock Option (Right to Buy) | 116,150 | — | — | 116,150 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (58,850 shares) |
| 2026-09-01 | Grant/award (116,150 shares) |
Keywords
insider transaction, Form 4, AURA, Aura Biosciences, Inc., neutral, Janet Jill Hopkins
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.